{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:06:10Z","timestamp":1783994770371,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Guilin Self-Financed Science and Technology Project","award":["NO. 20250109z"],"award-info":[{"award-number":["NO. 20250109z"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05225-4","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:12:27Z","timestamp":1779297147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CCDC78 is required for prostate cancer cell growth and serves as a prognostic biomarker for high-risk disease"],"prefix":"10.1007","volume":"17","author":[{"given":"Liangzhen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenken","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"5225_CR1","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians 2024.","DOI":"10.3322\/caac.21834"},{"issue":"3","key":"5225_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00345-018-2396-2","volume":"37","author":"SR Leyh-Bannurah","year":"2019","unstructured":"Leyh-Bannurah SR, Karakiewicz PI, Pompe RS, Preisser F, Zaffuto E, Dell\u2019Oglio P, Briganti A, Nafez O, Fisch M, Steuber T, et al. Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations. World J Urol. 2019;37(3):469\u201379.","journal-title":"World J Urol"},{"issue":"1","key":"5225_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5489\/cuaj.329","volume":"6","author":"S Sfoungaristos","year":"2012","unstructured":"Sfoungaristos S, Perimenis P. PSA density is superior than PSA and Gleason score for adverse pathologic features prediction in patients with clinically localized prostate cancer. Can Urol Association J = J de l\u2019Association des urologues du Can. 2012;6(1):46\u201350.","journal-title":"Can Urol Association J = J de l\u2019Association des urologues du Can"},{"issue":"2","key":"5225_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.mcna.2017.11.001","volume":"102","author":"WJ Catalona","year":"2018","unstructured":"Catalona WJ. Prostate Cancer Screening. Med Clin N Am. 2018;102(2):199\u2013214.","journal-title":"Med Clin N Am"},{"issue":"2","key":"5225_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.eururo.2018.01.043","volume":"74","author":"BA Mahal","year":"2018","unstructured":"Mahal BA, Yang DD, Wang NQ, Alshalalfa M, Davicioni E, Choeurng V, Schaeffer EM, Ross AE, Spratt DE, Den RB, et al. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer. Eur Urol. 2018;74(2):146\u201354.","journal-title":"Eur Urol"},{"issue":"12","key":"5225_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/jnci\/djp122","volume":"101","author":"MR Cooperberg","year":"2009","unstructured":"Cooperberg MR, Broering JM, Carroll PR. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009;101(12):878\u201387.","journal-title":"J Natl Cancer Inst"},{"key":"5225_CR7","unstructured":"Leslie SW, Soon-Sutton TL, Skelton WP. Prostate Cancer. In: StatPearls. edn. Treasure Island (FL) ineligible companies. Disclosure: Taylor Soon-Sutton declares no relevant financial relationships with ineligible companies. Disclosure: William Skelton declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC. 2025."},{"issue":"2","key":"5225_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nprot.2006.83","volume":"1","author":"P Chomczynski","year":"2006","unstructured":"Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc. 2006;1(2):581\u20135.","journal-title":"Nat Protoc"},{"issue":"12","key":"5225_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"10","key":"5225_CR10","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"key":"5225_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"5225_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12967-020-02698-x","volume":"19","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhang L, Wang J, Zhang M, Song Z, Ni B, You Y. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis. J translational Med. 2021;19(1):35.","journal-title":"J translational Med"},{"key":"5225_CR13","doi-asserted-by":"publisher","first-page":"601952","DOI":"10.3389\/fphys.2021.601952","volume":"12","author":"M Chen","year":"2021","unstructured":"Chen M, Chen S, Yang D, Zhou J, Liu B, Chen Y, Ye W, Zhang H, Ji L, Zheng Y. Weighted Gene Co-expression Network Analysis Identifies Crucial Genes Mediating Progression of Carotid Plaque. Front Physiol. 2021;12:601952.","journal-title":"Front Physiol"},{"issue":"4","key":"5225_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/jhered\/esac006","volume":"113","author":"L Yang","year":"2022","unstructured":"Yang L, Qu Q, Hao Z, Sha K, Li Z, Li S. Powerful Identification of Large Quantitative Trait Loci Using Genome-Wide R\/glmnet-Based Regression. J heredity. 2022;113(4):472\u20138.","journal-title":"J heredity"},{"key":"5225_CR15","doi-asserted-by":"crossref","unstructured":"Cai W, van der Laan M. Nonparametric bootstrap inference for the targeted highly adaptive least absolute shrinkage and selection operator (LASSO) estimator. Int J biostatistics 2020.","DOI":"10.1515\/ijb-2017-0070"},{"issue":"4","key":"5225_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385\u201395.","journal-title":"Stat Med"},{"issue":"4","key":"5225_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, Pfeil J, Narkizian J, Deran AD, Musselman-Brown A, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"5225_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18(1):11\u201322.","journal-title":"Cancer Cell"},{"issue":"7801","key":"5225_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","volume":"580","author":"J Li","year":"2020","unstructured":"Li J, Xu C, Lee HJ, Ren S, Zi X, Zhang Z, Wang H, Yu Y, Yang C, Gao X, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature. 2020;580(7801):93\u20139.","journal-title":"Nature"},{"issue":"2","key":"5225_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.cell.2015.06.053","volume":"162","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015;162(2):454.","journal-title":"Cell"},{"issue":"7406","key":"5225_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487(7406):239\u201343.","journal-title":"Nature"},{"issue":"5","key":"5225_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"23","key":"5225_CR23","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, Li X, Ochoa A, Zhao G, Lai B, et al. Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Res. 2023;83(23):3861\u20137.","journal-title":"Cancer Res"},{"issue":"W1","key":"5225_CR24","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"5225_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41585-023-00738-x","volume":"20","author":"R Silvestri","year":"2023","unstructured":"Silvestri R, Nicol\u00ec V, Gangadharannambiar P, Crea F, Bootman MD. Calcium signalling pathways in prostate cancer initiation and progression. Nat reviews Urol. 2023;20(9):524\u201343.","journal-title":"Nat reviews Urol"},{"issue":"6","key":"5225_CR26","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser C, Favero F, Risch T, Simon R, Feuerbach L, Assenov Y, Heckmann D, Sidiropoulos N, Waszak SM, H\u00fcbschmann D, et al. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories. Cancer Cell. 2018;34(6):996\u2013e10111018.","journal-title":"Cancer Cell"},{"key":"5225_CR27","doi-asserted-by":"publisher","first-page":"104235","DOI":"10.1016\/j.cellimm.2020.104235","volume":"358","author":"J Odales","year":"2020","unstructured":"Odales J, Guzman Valle J, Mart\u00ednez-Cort\u00e9s F, Manoutcharian K. Immunogenic properties of immunoglobulin superfamily members within complex biological networks. Cell Immunol. 2020;358:104235.","journal-title":"Cell Immunol"},{"issue":"1","key":"5225_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/01.ju.0000132135.18093.d6","volume":"172","author":"PD Sved","year":"2004","unstructured":"Sved PD, Gomez P, Manoharan M, Kim SS, Soloway MS. Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer. J Urol. 2004;172(1):98\u2013102.","journal-title":"J Urol"},{"issue":"S1","key":"5225_CR29","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1038\/modpathol.2017.158","volume":"31","author":"AJ Evans","year":"2018","unstructured":"Evans AJ. Treatment effects in prostate cancer. Mod pathology: official J United States Can Acad Pathol Inc. 2018;31(S1):S110\u2013121.","journal-title":"Mod pathology: official J United States Can Acad Pathol Inc"},{"issue":"2","key":"5225_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016;40(2):244\u201352.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"5225_CR31","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1080\/21655979.2021.1960764","volume":"12","author":"B Chen","year":"2021","unstructured":"Chen B, Xie X, Lan F, Liu W. Identification of prognostic markers by weighted gene co-expression network analysis in non-small cell lung cancer. Bioengineered. 2021;12(1):4924\u201335.","journal-title":"Bioengineered"},{"issue":"1","key":"5225_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12864-017-3761-z","volume":"18","author":"R Liu","year":"2017","unstructured":"Liu R, Zhang W, Liu ZQ, Zhou HH. Associating transcriptional modules with colon cancer survival through weighted gene co-expression network analysis. BMC Genomics. 2017;18(1):361.","journal-title":"BMC Genomics"},{"issue":"6","key":"5225_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.21037\/atm-22-399","volume":"10","author":"Y Bian","year":"2022","unstructured":"Bian Y, Huang J, Zeng Z, Yao H, Tu J, Wang B, Zou Y, Xie X, Shen J. Construction of survival-related co-expression modules and identification of potential prognostic biomarkers of osteosarcoma using WGCNA. Annals translational Med. 2022;10(6):296.","journal-title":"Annals translational Med"},{"issue":"1","key":"5225_CR34","doi-asserted-by":"publisher","first-page":"34762","DOI":"10.1038\/s41598-025-18567-w","volume":"15","author":"CD Young","year":"2025","unstructured":"Young CD, Carey KM, Dill CD, Nunez SK, Griffen TL, Dammer EB, Lillard JW Jr. Integrated systems biology reveals an 8-gene signature predicting early-stage lung adenocarcinoma progression and patient survival. Sci Rep. 2025;15(1):34762.","journal-title":"Sci Rep"},{"issue":"2","key":"5225_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5306\/wjco.v5.i2.71","volume":"5","author":"GS Christodoulatos","year":"2014","unstructured":"Christodoulatos GS, Dalamaga M. Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis? World J Clin Oncol. 2014;5(2):71\u201381.","journal-title":"World J Clin Oncol"},{"key":"5225_CR36","doi-asserted-by":"publisher","first-page":"811585","DOI":"10.3389\/fcell.2021.811585","volume":"9","author":"S Zhang","year":"2021","unstructured":"Zhang S, Jiang H, Gao B, Yang W, Wang G. Identification of Diagnostic Markers for Breast Cancer Based on Differential Gene Expression and Pathway Network. Front cell Dev biology. 2021;9:811585.","journal-title":"Front cell Dev biology"},{"key":"5225_CR37","doi-asserted-by":"crossref","unstructured":"Lopergolo D, Gallus GN, Pieraccini G, Boscaro F, Berti G, Serni G, Volpi N, Formichi P, Bianchi S, Cassandrini D et al. CCDC78: Unveiling the Function of a Novel Gene Associated with Hereditary Myopathy. Cells 2024;13(17).","DOI":"10.3390\/cells13171504"},{"key":"5225_CR38","doi-asserted-by":"publisher","first-page":"1092678","DOI":"10.3389\/fgene.2022.1092678","volume":"13","author":"W Wu","year":"2022","unstructured":"Wu W, Liu S, Tian L, Li C, Jiang Y, Wang J, Lv Y, Guo J, Xing D, Zhai Y, et al. Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction. Front Genet. 2022;13:1092678.","journal-title":"Front Genet"},{"issue":"19","key":"5225_CR39","doi-asserted-by":"publisher","first-page":"8710","DOI":"10.18632\/aging.102365","volume":"11","author":"H Yang","year":"2019","unstructured":"Yang H, Liu H, Lin HC, Gan D, Jin W, Cui C, Yan Y, Qian Y, Han C, Wang Z. Association of a novel seven-gene expression signature with the disease prognosis in colon cancer patients. Aging. 2019;11(19):8710\u201327.","journal-title":"Aging"},{"key":"5225_CR40","doi-asserted-by":"publisher","first-page":"1476092","DOI":"10.3389\/fgene.2025.1476092","volume":"16","author":"W Jin","year":"2025","unstructured":"Jin W, Lu Y, Lu J, Wang Z, Yan Y, Liang B, Qian S, Ni J, Yang Y, Huang S, et al. Identification of cancer-associated fibroblast signature genes for prognostic prediction in colorectal cancer. Front Genet. 2025;16:1476092.","journal-title":"Front Genet"},{"issue":"7","key":"5225_CR41","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.62347\/THYT9980","volume":"15","author":"J Gong","year":"2025","unstructured":"Gong J, Xia B, Qian L, Cai Y. Transcriptomic validation and clinical translation of CCDC78 as a prognostic biomarker in colorectal cancer. Am J cancer Res. 2025;15(7):3245\u201366.","journal-title":"Am J cancer Res"},{"issue":"7","key":"5225_CR42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.trecan.2019.05.010","volume":"5","author":"GL Szeto","year":"2019","unstructured":"Szeto GL, Finley SD. Integrative Approaches to Cancer Immunotherapy. Trends cancer. 2019;5(7):400\u201310.","journal-title":"Trends cancer"},{"key":"5225_CR43","doi-asserted-by":"publisher","first-page":"217155","DOI":"10.1016\/j.canlet.2024.217155","volume":"601","author":"D Liu","year":"2024","unstructured":"Liu D, Wang L, Guo Y. Advances in and prospects of immunotherapy for prostate cancer. Cancer Lett. 2024;601:217155.","journal-title":"Cancer Lett"},{"issue":"10","key":"5225_CR44","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.xcrm.2023.101199","volume":"4","author":"D Sridaran","year":"2023","unstructured":"Sridaran D, Bradshaw E, DeSelm C, Pachynski R, Mahajan K, Mahajan NP. Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach. Cell Rep Med. 2023;4(10):101199.","journal-title":"Cell Rep Med"},{"issue":"1","key":"5225_CR45","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s41467-018-03573-6","volume":"9","author":"L Latonen","year":"2018","unstructured":"Latonen L, Afyounian E, Jylh\u00e4 A, N\u00e4ttinen J, Aapola U, Annala M, Kivinummi KK, Tammela TTL, Beuerman RW, Uusitalo H, et al. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression. Nat Commun. 2018;9(1):1176.","journal-title":"Nat Commun"},{"issue":"5","key":"5225_CR46","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.eururo.2015.10.053","volume":"69","author":"D Iglesias-Gato","year":"2016","unstructured":"Iglesias-Gato D, Wikstr\u00f6m P, Tyanova S, Lavallee C, Thysell E, Carlsson J, H\u00e4ggl\u00f6f C, Cox J, Andr\u00e9n O, Stattin P, et al. The Proteome of Primary Prostate Cancer. Eur Urol. 2016;69(5):942\u201352.","journal-title":"Eur Urol"},{"key":"5225_CR47","doi-asserted-by":"publisher","first-page":"100026","DOI":"10.1074\/mcp.RA120.002320","volume":"20","author":"R Kawahara","year":"2021","unstructured":"Kawahara R, Recuero S, Srougi M, Leite KRM, Thaysen-Andersen M, Palmisano G. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression. Mol Cell proteomics: MCP. 2021;20:100026.","journal-title":"Mol Cell proteomics: MCP"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05225-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05225-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05225-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:01:59Z","timestamp":1783994519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05225-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5225"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05225-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the declaration of Helsinki. The ethics committee of Nanxishan Hospital of Guangxi Zhuang Autonomous Region has approved the study on February 20, 2024. And the ethics review number is NXSYY-2024-171-01.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Written informed consent was obtained from every participant after the study purpose, procedures, and potential risks had been fully explained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1017"}}